Biodesix, Inc

We are a molecular diagnostics company at the forefront of innovation in oncology. We discover, develop and deliver blood-based diagnostics to answer unmet clinical questions across the continuum of lung cancer and improve the standard of care for patients.

We see both sides of lung cancer with our Biodesix Lung Reflex® testing strategy by integrating the GeneStrat® genomic test and the VeriStrat® proteomic test. Results within 72-hours can inform a comprehensive treatment strategy and expedite time to treatment. A fast result turnaround time can reduce a patient’s time from diagnosis to treatment start.